These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 2479802)

  • 1. Augmentation of rat liver regeneration by FK 506 compared with cyclosporin.
    Francavilla A; Barone M; Todo S; Zeng Q; Porter KA; Starzl TE
    Lancet; 1989 Nov; 2(8674):1248-9. PubMed ID: 2479802
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Studies on mechanisms of augmentation of liver regeneration by cyclosporine and FK 506.
    Francavilla A; Starzl TE; Barone M; Zeng QH; Porter KA; Zeevi A; Markus PM; van den Brink MR; Todo S
    Hepatology; 1991 Jul; 14(1):140-3. PubMed ID: 1712337
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of cyclosporin A on hepatocyte proliferation after partial hepatectomy in rats: comparison with standard immunosuppressive agents.
    Kim YI; Salvini P; Auxilia F; Calne RY
    Am J Surg; 1988 Feb; 155(2):245-9. PubMed ID: 3341550
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Liver regeneration during immunosuppression.
    Coughlin JP; Austen WG; Donahoe PK; Russell WE
    J Pediatr Surg; 1987 Jun; 22(6):566-70. PubMed ID: 3612448
    [TBL] [Abstract][Full Text] [Related]  

  • 5. FK 506 as a growth control factor.
    Francavilla A; Barone M; Starzl TE; Zeevi A; Scotti C; Carrieri G; Mazzaferro V; Prelich J; Todo S; Eiras G
    Transplant Proc; 1990 Feb; 22(1):90-2. PubMed ID: 1689912
    [No Abstract]   [Full Text] [Related]  

  • 6. Enhanced liver regeneration in rats treated with 15-deoxyspergualin alone and in combination with FK 506.
    Ohtake M; Okamura N; Sakaguchi T; Aono T; Koyama S; Tsukada K; Yoshida K; Muto T
    Gastroenterol Jpn; 1993 Apr; 28(2):249-53. PubMed ID: 7683616
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cyclosporin A stimulates proliferation of the liver cells after partial hepatectomy in rats.
    Kim YI; Calne RY; Nagasue N
    Surg Gynecol Obstet; 1988 Apr; 166(4):317-22. PubMed ID: 3353828
    [TBL] [Abstract][Full Text] [Related]  

  • 8. FK 506: an immunosuppressant for the 1990s?
    Macleod AM; Thomson AW
    Lancet; 1991 Jan; 337(8732):25-7. PubMed ID: 1702172
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of FK 506 and CyA on the Lewis rat renal ischemia model.
    Nalesnik MA; Lai HS; Murase N; Todo S; Starzl TE
    Transplant Proc; 1990 Feb; 22(1):87-9. PubMed ID: 1689911
    [No Abstract]   [Full Text] [Related]  

  • 10. Biopharmaceutical aspects of FK-506.
    Venkataramanan R; Warty VS; Zemaitis MA; Sanghvi AT; Burckart GJ; Seltman H; Todo S; Makowka L; Starzl TE
    Transplant Proc; 1987 Oct; 19(5 Suppl 6):30-5. PubMed ID: 2445070
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of the immunosuppressant FK-506 and its analog FK-520 on hepatic and renal cytochrome P450 mixed-function oxidase.
    Vincent SH; Wang RW; Karanam BV; Klimko M; Alvaro R; Chiu SH
    Biochem Pharmacol; 1991 May; 41(9):1325-30. PubMed ID: 1708254
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatotrophic effect of cyclosporine and FK 506 is not mimicked by rapamycin.
    Chávez R; Jamieson N; Takamori S; Nivatvongs S; Pino G; Metcalfe A; Watson C; Romero D; Metcalfe S
    Transplant Proc; 1999 Sep; 31(6):2429. PubMed ID: 10500655
    [No Abstract]   [Full Text] [Related]  

  • 13. Studies of the hepatotrophic qualities of FK 506 and CyA.
    Mazzaferro V; Scotti-Foglieni CL; Porter KA; Trejo Bellido J; Carrieri G; Todo S; Fung JJ; Francavilla A; Starzl TE
    Transplant Proc; 1990 Feb; 22(1):93-5. PubMed ID: 1689913
    [No Abstract]   [Full Text] [Related]  

  • 14. Comparative immunopharmacologic effects of FK 506 and CyA in in vivo models of organ transplantation.
    Morris RE; Wu J; Shorthouse R
    Transplant Proc; 1990 Feb; 22(1):110-2. PubMed ID: 1689885
    [No Abstract]   [Full Text] [Related]  

  • 15. Pharmacokinetics of FK 506 following oral administration: a comparison of FK 506 and cyclosporine.
    Venkataramanan R; Jain A; Warty VW; Abu-Elmagd K; Furakawa H; Imventarza O; Fung J; Todo S; Starzl TE
    Transplant Proc; 1991 Feb; 23(1 Pt 2):931-3. PubMed ID: 1703355
    [No Abstract]   [Full Text] [Related]  

  • 16. Pharmacokinetics of FK-506, a novel immunosuppressant, after intravenous and oral administrations to rats.
    Takada K; Usuda H; Oh-Hashi M; Yoshikawa H; Muranishi S; Tanaka H
    J Pharmacobiodyn; 1991 Jan; 14(1):34-42. PubMed ID: 1713626
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparative study between cyclosporine and FK 506 effects on renal microsomal P-450.
    Yoshimura R; Yoshimura N; Kusunose E; Hamashima T; Ohsaka Y; Kusunose M; Oka T; Kishimoto T; Maekawa M
    Transplant Proc; 1991 Feb; 23(1 Pt 1):311-3. PubMed ID: 1703686
    [No Abstract]   [Full Text] [Related]  

  • 18. Assessment of Effect of Intraperitoneal Tacrolimus on Liver Regeneration in Major (70%) Hepatectomy Model After Experimental Pringle Maneuver in Rats.
    Karadeniz E; Ozbilgin M; Egeli T; Agalar C; Cevlik AD; Aysal A; Ellidokuz H; Unek T; Astarcioglu I
    Transplant Proc; 2019 May; 51(4):1172-1179. PubMed ID: 31101194
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of the effects of FK506 and cyclosporine on bone mineral metabolism in the rat. A pilot study.
    Katz IA; Takizawa M; Jaffe II; Stein B; Fallon MD; Epstein S
    Transplantation; 1991 Sep; 52(3):571-4. PubMed ID: 1716801
    [No Abstract]   [Full Text] [Related]  

  • 20. Effect of FK 506 on spontaneous diabetes in BB rats.
    Murase N; Lieberman I; Nalesnik MA; Mintz DH; Todo S; Drash AL; Starzl TE
    Diabetes; 1990 Dec; 39(12):1584-6. PubMed ID: 1700959
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.